The Claim
Melatonin supplementation improves subjective sleep quality and reduces insomnia symptoms, including decreased daytime sleepiness, in patients with Parkinson's disease.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking melatonin helps people with Parkinson's disease sleep better and feel less sleepy during the day. It reduces their insomnia symptoms and helps them feel more rested compared to not taking it.
See the scientific wording
Melatonin supplementation improves subjective sleep quality and reduces insomnia symptoms in patients with Parkinson's disease, as evidenced by statistically significant reductions in Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale scores across multiple randomized controlled trials. These findings indicate that patients report feeling more rested and experience less daytime sleepiness when treated with melatonin compared to control conditions.
What the research says
1 studyThe study confirms that melatonin pills help Parkinson's patients sleep better and feel less sleepy during the day, showing clear statistical improvements in sleep questionnaires, though the actual benefit might be too small to feel dramatically different in daily life.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.